Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ or system. Neuropsychiatric and pulmonary involvement can occur in 40 and 50% of patients respectively, and may occur in several different clinical forms. While the main neuropsychiatric manifestations are represented by cognitive impairment, organic cerebral syndromes, delirium, psychosis, seizures, and peripheral neuropathies, the main forms of pulmonary involvement are pleurisy with or without pleural effusion, pneumonitis, interstitial disease, pulmonary hypertension, and alveolar hemorrhage. The authors report the case of a 49-year-old woman whose first manifestation of SLE was represented by two rare manifestations: rapidly progressive cognitive impairment, which was associated with respiratory failure caused by the shrinking lung syndrome. The authors call attention to the under-diagnosis of lupus pulmonary complications and its association with severe cognitive impairment that often necessitates aggressive treatment.
KozoraE, HanlyJG, LaptevaL, FilleyCM. Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. Arthritis Rheum. 2008;58(11):3286-98. [https://doi.org/10.1002/art.23991]. [PMID:18975345]
HendersonLA, LoringSH, GillRR, et al. Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies. J Rheumatol. 2013;40(3):273-81. [https://doi.org/10.3899/jrheum.121048]. [PMID:23378468]
TomiettoP, AnneseV, D’agostiniS, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 2007;57(8):1461-72. [https://doi.org/10.1002/art.23098]. [PMID:18050188]
BhangleSD, KramerN, RosensteinED. Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int. 2013;33(8):1923-32. [https://doi.org/10.1007/s00296-013-2750-z]. [PMID:23588411]
DenburgSD, CarbotteRM, DenburgJA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 1994;37(9):1311-20. [https://doi.org/10.1002/art.1780370907]. [PMID:7945494]
SilbersteinSL, BarlandP, GrayzelAI, KoernerSK. Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ involvement. J Rheumatol. 1980;7(2):187-95. [PMID:7373620].
BertoliAM, VilaLM, ApteM, et al. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus. 2007;16(6):410-7. [https://doi.org/10.1177/0961203307079042]. [PMID:17664231]
PillaiS, MehtaJ, LevinT, MuzumdarH, NandalikeK. Shrinking lung syndrome presenting as an initial pulmonary manifestation of SLE. Lupus. 2014;23(11):1201-3. [https://doi.org/10.1177/0961203314536248]. [PMID:24836585]
SantisM, MartinsV, MoitaJ. Síndroma do pulmão encolhido: Relato de um caso clínico e revisão da literatura. Rev Port Pneumol. 2010;16(4):687-91. [Portuguese.]. [PMID:20700566]
CalderaroDC, FerreiraGA. Presentation and prognosis of shrinking lung syndrome in systemic lupus erythematosus: report of four cases. Rheumatol Int. 2012;32(5):1391-6. [https://doi.org/10.1007/s00296-011-1863-5]. [PMID:21431288]
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email